Qingchang Mixture Prevents the Intestinal Ischemia-reperfusion Injury Through TLR4/NF-kB Pathway
Abstract Background: This study was performed to determine the protection and molecular responses of Chinese medicine Qingchang mixture on intestinal ischemia-reperfusion (IR) injury.Methods: The rat intestinal IR model was prepared. Intestinal ischemic injury was evaluated by the HE staining, biochemical assay and western blot. In addition, human intestinal epithelial cells (IEC-6) hypoxia-reoxygenation (HR) in vitro model was prepared. The viability and apoptosis of IEC-6 cells were measured by CCK8 and apoptosis detection. TAK242 or PDTC was used as the small molecule inhibitor of TLR4 or NF-κB.Results: Compared with the IR group, the pretreatment of Qingchang mixture relieved the morphological damage, oxidative stress, inflammatory response and barrier function damage of small intestine tissue. IR significantly increased the expression of TLR4 and NF-κB, while the pretreatment of Qingchang mixture inhibited the expression of TLR4 and NF-κB. Furthermore, the pretreatment of Qingchang mixture, TAK242 or PDTC effectively improved the viability, and hindered apoptosis of the HR-induced IEC-6 cells.Conclusions: Chinese medicine Qingchang mixture prevents the intestinal IR injury through TLR4/NF-kB pathway.